Increased Expression	1
Cyclo-Oxygenase 2 and Vascular Endothelial Growth Factor in Lesioned Spinal Cord	25
Cyclo-Oxygenase 2	25
Vascular Endothelial Growth Factor in Lesioned Spinal Cord	47
Vascular Endothelial Growth Factor	47
Lesioned Spinal Cord	85
Olfactory Ensheathing Cells	122
LÓPEZ-VALES ,1 GUILLERMO GARCÍA-ALÍAS	157
,1 JOAQUIM FORÉS ,1,2 XAVIER NAVARRO ,1	193
,1 JOAQUIM FORÉS	193
,1,2 XAVIER NAVARRO ,1	209
ENRIQUE VERDÚ1 ABSTRACT Olfactory ensheathing cells -LRB- OECs -RRB-	235
ENRIQUE VERDÚ1 ABSTRACT	235
Olfactory ensheathing cells -LRB- OECs -RRB-	260
Olfactory ensheathing cells	260
OECs	289
adult rats	316
photochemical injury of the spinal cord	333
photochemical injury	333
the spinal cord	357
Rats	374
180,000 OECs suspended in DMEM or DMEM alone	395
180,000 OECs	395
DMEM or DMEM	421
Locomotor ability	441
the BBB-scale , pain sensibility , and motor and somatosensory	469
the BBB-scale	469
pain sensibility	484
motor and somatosensory	506
potentials	537
the first 14 days	570
3 , 7 , and 14 days	605
3	605
7	608
14 days	615
5 rats per day of both groups	624
5 rats	624
day of both groups	635
day	635
both groups	642
transverse sections from proximal , lesioned and distal spinal cord blocks	672
transverse sections	672
proximal , lesioned and distal spinal cord blocks	697
COX-2 , VEGF , GFAP and lectin	763
The BBB-score and the amplitude of motor and somatosensory	793
The BBB-score	793
the amplitude of motor and somatosensory	811
the amplitude	811
motor and somatosensory	828
potentials	859
OEC	899
DMEM-injected animals throughout follow-up	912
DMEM-injected animals	912
follow-up	945
the withdrawal latency to heat noxious stimulus	964
the withdrawal latency	964
heat noxious stimulus	990
OEC	1025
DMEM-injected rats	1038
The area of preserved spinal cord and the levels of COX-2 and VEGF staining	1058
The area of preserved spinal cord	1058
The area	1058
preserved spinal cord	1070
the levels of COX-2 and VEGF staining	1096
the levels	1096
COX-2 and VEGF staining	1110
OEC	1163
DMEM-injected rats	1176
no LEC-positive cells	1206
COX-2 staining	1238
COX-2	1238
staining	1244
OEC-transplanted rats	1256
The density of blood vessels	1279
The density	1279
blood vessels	1294
OEC	1344
respect	1354
DMEM-injected rats	1365
Our results	1385
OECs	1407
functional and morphological preservation of the spinal cord	1420
functional and morphological preservation	1420
the spinal cord	1465
photochemical injury	1487
increasing neoangiogenesis	1509
up-regulation of COX-2 and VEGF expression in astrocytes	1540
up-regulation	1540
COX-2 and VEGF expression in astrocytes	1557
COX-2 and VEGF expression	1557
astrocytes	1586
INTRODUCTION ENDOTHELIAL DAMAGE , release of inflammatory mediators	1599
INTRODUCTION ENDOTHELIAL DAMAGE	1599
release of inflammatory mediators	1632
release	1632
inflammatory mediators	1643
changes in vascular permeability	1667
changes	1667
vascular permeability	1678
edema , infiltration of inflammatory cells	1701
edema	1701
infiltration of inflammatory cells	1708
infiltration	1708
inflammatory cells	1724
activation of astrocytes and microglia	1748
activation	1748
astrocytes and microglia	1762
pathophysiological findings	1791
spinal cord injury -LRB- Schwab and Bartholdi , 1996 -RRB-	1834
spinal cord injury	1834
Schwab and Bartholdi	1854
1996	1876
Experimental evidence	1883
these responses	1919
they	2011
Schwartz , 2000 ; Bethea and Dietrich , 2002	2071
Schwartz	2071
2000 ; Bethea and Dietrich	2081
2000	2081
Bethea and Dietrich	2087
2002	2108
complete transection of spinal cord	2121
complete transection	2121
spinal cord	2145
local administration of pre-activated macrophages	2158
local administration	2158
pre-activated macrophages	2182
axonal regrowth -LRB- Rapalino et al. , 1998 -RRB-	2217
axonal regrowth	2217
Rapalino	2234
et al. , 1998	2243
et al.	2243
1998	2251
Cytokines and growth factors	2258
macrophages	2299
activated microglia and astrocytes	2324
this effect -LRB- Rapalino et al. , 1998 -RRB-	2371
this effect	2371
Rapalino	2384
et al. , 1998	2393
et al.	2393
1998	2401
the context of spinal cord trauma	2411
the context	2411
spinal cord trauma	2426
it	2446
a matter of controversy	2458
a matter	2458
controversy	2470
cytokines	2490
a beneficial or a detrimental effect	2505
the injured tissue -LRB- Hirschberg et al. , 1994 ; Bethea et al. , 1999 -RRB-	2545
the injured tissue	2545
Hirschberg	2565
et al. , 1994 ; Bethea et al. , 1999	2576
et al.	2576
1994 ; Bethea et al.	2584
1994	2584
Bethea et al.	2590
Bethea	2590
et al.	2597
1999	2605
Cytokines and other factors	2612
Cytokines	2612
other factors	2626
distinctive and possible opposing effects	2650
the phase of recovery	2706
the phase	2706
recovery	2719
rescue or regrowth	2743
Schwartz et al. , 1996 ; Schwartz , 2000	2789
Schwartz	2789
et al. , 1996 ; Schwartz , 2000	2798
et al. , 1996	2798
et al.	2798
1996	2806
Schwartz , 2000	2812
Schwartz	2812
2000	2822
Activation	2829
cyclo-oxygenase -LRB- COX -RRB-	2843
cyclo-oxygenase	2843
COX	2860
inducible nitric oxide synthase -LRB- iNOS -RRB-	2866
inducible nitric oxide synthase	2866
iNOS	2899
their products	2909
the lesion site	2933
the acute phase -LRB- Schwab and Bartholdi , 1996 -RRB-	2956
the acute phase	2956
Schwab and Bartholdi	2973
1996	2995
COX-2 mRNA	3002
mechanical injury	3029
the spinal cord -LRB- Resnick et al. , 1998 ; Tonai et al. , 1999 -RRB-	3050
the spinal cord	3050
Resnick	3067
et al. , 1998 ; Tonai et al. , 1999	3075
et al.	3075
1998 ; Tonai et al.	3083
1998	3083
Tonai et al.	3089
Tonai	3089
et al.	3095
1999	3103
intraspinal injection of interleukin-1 -LRB- Tonai et al. , 1999 -RRB-	3120
intraspinal injection	3120
interleukin-1 -LRB- Tonai et al. , 1999 -RRB-	3145
interleukin-1	3145
Tonai	3160
et al. , 1999	3166
et al.	3166
1999	3174
COX-2 expression	3181
hypoxia , peroxidation and excitatory amino acid	3217
neuronal death	3273
spinal cord injury -LRB- Siesjo , 1992 -RRB-	3294
spinal cord injury	3294
Siesjo	3314
1992	3322
Sköld et al. -LRB- 2000 -RRB-	3339
Sköld et al.	3339
Sköld	3339
et al.	3345
2000	3353
vascular endothelial growth factor -LRB- VEGF -RRB- and its receptors	3373
vascular endothelial growth factor -LRB- VEGF -RRB-	3373
vascular endothelial growth factor	3373
VEGF	3409
its receptors	3419
mechanical spinal cord injury	3451
Intraspinal injections of PGF2alpha	3482
Intraspinal injections	3482
PGF2alpha	3508
the expression of VEGF mRNA and protein	3538
the expression	3538
VEGF mRNA and protein	3556
the injection area -LRB- Sköld et al. , 2000 -RRB-	3581
the injection area	3581
Sköld	3601
et al. , 2000	3607
et al.	3607
2000	3615
These findings	3622
prostaglandins , a product of the COX-2 pathway ,	3650
prostaglandins	3650
a product of the COX-2 pathway	3666
a product	3666
the COX-2 pathway	3679
the expression	3707
VEGF	3725
a growth factor	3731
endothelial cell proliferation , angiogenesis and vascular permeability	3759
Proescholdt	3831
et al. , 1999	3843
et al.	3843
1999	3851
We	3858
transplants of olfactory ensheathing glia cells -LRB- OECs -RRB-	3886
transplants	3886
olfactory ensheathing glia cells -LRB- OECs -RRB-	3901
olfactory ensheathing glia cells	3901
OECs	3935
spinal cord parenchyma preservation	3964
photochemical spinal cord injury -LRB- Verdú et al. , 2001 , 2003a -RRB-	4006
photochemical spinal cord injury	4006
Verdú	4040
et al. , 2001 , 2003a	4046
et al.	4046
2001	4054
2003a	4060
the mechanisms implicated in this neuroprotective role	4077
the mechanisms	4077
this neuroprotective role	4106
This report	4151
OEC transplants	4199
the immune and inflammatory responses	4235
spinal cord injury	4279
We	4299
OECs transplants	4320
the expression of COX-2 and VEGF	4348
the expression	4348
COX-2 and VEGF	4366
neoangiogenesis in the injured spinal cord parenchyma	4394
neoangiogenesis	4394
the injured spinal cord parenchyma	4413
the first days postlesion	4455
MATERIALS AND METHODS	4483
MATERIALS	4483
METHODS	4497
Primary Cultures of OECs , Immunopurification , and Cryopreservation OECs	4505
Primary Cultures	4505
OECs , Immunopurification , and Cryopreservation OECs	4525
primary cultures of olfactory bulbs	4596
primary cultures	4596
olfactory bulbs	4616
adult -LRB- 2.5 -- 3.0 months old -RRB- female Sprague-Dawley rats	4638
2.5 -- 3.0 months old	4645
2.5	4645
3.0 months old	4649
the method described by Gudiño-Cabrera and Nieto-Sampedro	4699
the method	4699
Gudiño-Cabrera and Nieto-Sampedro	4723
1996	4758
2000	4764
minor modifications -LRB- Verdú et al. , 2003a -RRB-	4775
minor modifications	4775
Verdú	4796
et al. , 2003a	4802
et al.	4802
2003a	4810
the bulbs	4827
Hank 's balanced salt solution -LRB- HBSS , H-6136 , Sigma , St Louis , MO -RRB-	4876
Hank 's balanced salt solution	4876
Hank 's	4876
HBSS , H-6136 , Sigma , St Louis , MO	4907
HBSS	4907
H-6136	4913
Sigma	4921
St Louis	4928
MO	4938
calcium and magnesium	4947
0 °C	4972
The meningeal layer	4977
fine forceps	5019
the bulbs	5037
0.25 % trypsin -LRB- GIBCO , Life Technologies , Paisley , Scotland -RRB-	5065
0.25 % trypsin	5065
GIBCO	5080
Life Technologies	5087
Paisley , Scotland	5106
0.1 % collagenase A -LRB- GIBCO , Life Technologies -RRB-	5126
0.1 % collagenase A	5126
GIBCO	5146
Life Technologies	5153
0.1 % DNAse-I -LRB- Boehringer Mannheim , Germany -RRB-	5176
0.1 % DNAse-I	5176
Boehringer Mannheim	5190
Germany	5211
1 mL of HBSS	5223
1 mL	5223
HBSS	5231
calcium and magnesium -LRB- H-2387 , Sigma -RRB- at 37 °C for 45 -- 60 min	5244
calcium and magnesium -LRB- H-2387 , Sigma -RRB- at 37 °C for 45	5244
calcium and magnesium -LRB- H-2387 , Sigma -RRB-	5244
calcium and magnesium	5244
H-2387	5267
Sigma	5275
37 °C for 45	5285
37 °C	5285
45	5294
60 min	5297
incubation	5311
tissue	5323
a flame-constricted Pasteur pipette	5365
enzymes	5405
the addition	5433
10 mL	5449
Dulbecco 's minimum essential medium nutrient mixture F-12 Ham	5458
Dulbecco 's	5458
DMEM	5521
D-8900	5527
Sigma	5535
10 % fetal calf serum	5547
FCS	5569
Biological Industries	5574
Israel	5597
The cell mixture	5606
centrifugation	5640
900 rpm for 7 min	5658
900 rpm	5658
7 min	5670
culture medium	5695
Cells	5711
25 cm2 flasks	5739
poly-Llysine -LRB- 10 µg/mL , P-7890 , Sigma -RRB-	5765
poly-Llysine	5765
10 µg/mL	5779
P-7890	5789
Sigma	5797
5 % CO2 at 37 °C	5822
5 % CO2	5822
37 °C	5832
Culture medium	5838
DMEM with 10 % FCS	5857
DMEM	5857
10 % FCS	5867
9 days in vitro	5879
9 days	5879
this medium	5896
a defined medium	5924
OECs -LRB- Gudiño-Cabrera and Nieto-Sampedro , 2000 -RRB-	5955
OECs	5955
Gudiño-Cabrera and Nieto-Sampedro , 2000	5961
Gudiño-Cabrera and Nieto-Sampedro	5961
2000	5996
confluence -LRB- 12 -- 15 days in vitro -RRB-	6018
confluence	6018
12	6030
15 days in vitro	6033
15 days	6033
vitro	6044
OECs	6052
incubation	6074
trypsin-EDTA -LRB- T - 3924 , Sigma -RRB-	6090
trypsin-EDTA	6090
T	6104
3924 , Sigma	6107
3924	6107
Sigma	6113
Trypsin action	6121
addition of medium	6152
addition	6152
medium	6164
the cell mixture	6175
centrifugation	6209
900 rpm for 7 min	6227
900 rpm	6227
7 min	6239
OECs	6246
mean of magnetic Dynabeads M-450 -LRB- DBM-450 , Dynal , Oslo , Norway -RRB-	6274
mean of magnetic Dynabeads M-450	6274
mean	6274
magnetic Dynabeads	6282
DBM-450	6308
Dynal	6317
Oslo , Norway	6324
goat anti-mouse IgG	6354
mouse	6392
monoclonal 192 IgG antibodies	6398
192	6409
MAB365	6429
Chemicon	6437
Temecula , CA	6447
the p75-NGF receptor -LRB- Gudiño-Cabrera and Nieto - Sampedro , 1996 -RRB-	6476
the p75-NGF receptor	6476
Gudiño-Cabrera and Nieto - Sampedro , 1996	6498
Gudiño-Cabrera and Nieto - Sampedro	6498
Gudiño-Cabrera and Nieto	6498
Gudiño-Cabrera	6498
Nieto	6517
Sampedro	6524
1996	6534
the p75-positive cells	6550
freezing medium -LRB- C-6295 , Sigma -RRB-	6593
freezing medium	6593
C-6295	6610
Sigma	6618
4 °C , transferred to -20 °C for 10 min , then to a deep freezer at -80 °C	6639
4 °C	6639
-20 °C for 10 min	6659
-20 °C	6659
10 min	6669
a deep freezer at -80 °C	6685
a deep freezer	6685
-80 °C	6703
transplantation	6714
frozen cell vials	6731
37 °C	6764
two times	6777
centrifugation	6790
900 rpm , 7 min	6806
900 rpm	6806
7 min	6815
DMEM	6825
the pellet resuspended in the same medium	6835
the pellet	6835
the same medium	6861
The cells	6878
2 h of thawing	6913
2 h	6913
thawing	6920
our culture conditions	6935
more than 90 % of cells in primary cultures	6959
more than 90 %	6959
cells in primary cultures	6976
cells	6976
primary cultures	6985
spindle-like morphology	7007
two or three processes	7036
less than 10 % of cells	7066
less than 10 %	7066
cells	7083
a flattened appearance	7093
A few macrophages/microglial cells	7117
the cultures	7176
accordance	7193
previous studies -LRB- Gudiño-Cabrera and Nieto - Sampedro , 1996 -RRB-	7209
previous studies	7209
Gudiño-Cabrera and Nieto - Sampedro , 1996	7227
Gudiño-Cabrera and Nieto - Sampedro	7227
Gudiño-Cabrera and Nieto	7227
Gudiño-Cabrera	7227
Nieto	7246
Sampedro	7253
1996	7263
more than 97 % of the immunopurified cells	7270
more than 97 %	7270
the immunopurified cells	7287
the majority of transplanted OECs	7345
the majority	7345
transplanted OECs	7361
spindle-shaped p75-positive cells	7383
Schwann-cell	7431
phenotype	7449
Gudiño	7460
Cabrera and Nieto-Sampedro	7468
1996 , 2000 ; Franceschini and Barnett , 1996 ; Wewetzer et al.	7496
1996 , 2000	7496
1996	7496
2000	7502
Franceschini and Barnett , 1996	7508
Franceschini and Barnett	7508
1996	7534
Wewetzer et al.	7540
Wewetzer	7540
et al.	7549
2000	7557
Trypan blue	7564
the viable cell number	7607
unstained cells	7643
a haemocytometer	7677
the percentage of cell viability	7698
the percentage	7698
cell viability	7716
The trypan blue stain test	7747
The trypan	7747
blue	7758
test	7769
three times	7787
Our counts	7800
the percentage of thawed viable cells	7823
the percentage	7823
thawed viable cells	7841
97 -- 98 % from the total cells	7871
97	7871
98 % from the total cells	7874
98 %	7874
the total cells	7883
Spinal Cord Injury	7900
OEC Transplantation	7923
Thirty adult female Sprague-Dawley rats -LRB- 250 -- 300 g -RRB-	7943
Thirty adult female Sprague-Dawley rats	7943
250 -- 300 g	7984
250	7984
300 g	7988
sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	8018
sodium pentobarbital	8018
50 mg/kg , i.p.	8040
50 mg/kg	8040
a heating pad	8076
body temperature constant	8102
The back of the animals	8129
The back	8129
the animals	8141
povidone iodine	8185
a longitudinal incision from mid to low thoracic vertebrae	8206
a longitudinal incision	8206
mid to low thoracic vertebrae	8235
The spinal cord	8275
a dorsal laminectomy of T8 vertebra	8306
a dorsal laminectomy	8306
T8 vertebra	8330
The dura	8343
penetration of solutions	8384
penetration	8384
solutions	8399
Rose Bengal -LRB- RB ; 1.5 % in saline , Sigma -RRB-	8410
Rose Bengal	8410
RB ; 1.5 % in saline , Sigma	8423
RB	8423
1.5 % in saline , Sigma	8427
1.5 %	8427
saline , Sigma	8435
saline	8435
Sigma	8443
the exposed spinal cord for 10 minutes	8474
the exposed spinal cord	8474
10 minutes	8502
this time	8521
the dye easily	8532
the	8532
the cord parenchyma	8558
the gray matter -LRB- Verdú et al. , 2003b -RRB-	8604
the gray matter	8604
Verdú	8621
et al. , 2003b	8627
et al.	8627
2003b	8635
the excess	8649
a double saline rinse	8679
The lesion	8702
the exposed dorsal surface of the spinal cord by means of a 5-mm diameter	8741
the exposed dorsal surface	8741
the spinal cord by means of a 5-mm diameter	8771
the spinal cord	8771
means of a 5-mm diameter	8790
means	8790
a 5-mm diameter	8799
optic fiber	8815
10 mm	8838
top of the cord -LRB- Verdú et al. , 2003a , b -RRB-	8847
top	8847
the cord -LRB- Verdú et al. , 2003a , b -RRB-	8854
the cord	8854
Verdú	8864
et al. , 2003a , b	8870
et al.	8870
2003a	8878
b	8884
The optic fiber	8888
a halogen lamp equipped with a 100 -- W Xenophot halogen bulb	8921
a halogen lamp	8921
a 100 -- W Xenophot halogen bulb	8950
a 100	8950
W Xenophot halogen bulb	8956
W Xenophot	8956
halogen bulb	8967
reproducible light intensity	8991
the irradiation power at the fiber outlet	9021
the irradiation power	9021
the fiber outlet	9046
means of a digital lux tester	9079
means	9079
a digital lux tester	9088
Spinal cord	9110
a light intensity of 200 kLux	9141
a light intensity	9141
200 kLux	9162
2.5 min	9178
damage	9198
the calorific source of the halogen lamp	9208
the calorific source	9208
the halogen lamp	9232
the illumination time	9257
the spinal cord	9279
saline solution	9311
this spinal cord injury	9353
cytotoxic edema	9384
astrocytic swelling	9405
red blood cell extravasation and myelin degradation	9426
Verdú	9479
et al. , 2003b	9485
et al.	9485
2003b	9493
Thirty minutes	9501
injury	9522
15 animals	9530
four injections of a suspension of OECs -LRB- 45000 in 3 µL of DMEM each -RRB-	9550
four injections	9550
a suspension of OECs -LRB- 45000 in 3 µL of DMEM each -RRB-	9569
a suspension	9569
OECs -LRB- 45000 in 3 µL of DMEM each -RRB-	9585
OECs	9585
45000 in 3 µL of DMEM each	9591
45000	9591
3 µL of DMEM each	9600
3 µL	9600
DMEM each	9608
DMEM	9608
each	9613
the exposed spinal cord -LRB- group OEC -RRB-	9624
the exposed spinal cord	9624
group OEC	9649
Two injections	9661
1 mm rostral and two injections 1 mm caudal	9689
1 mm rostral	9689
two injections 1 mm caudal	9706
two injections	9706
1 mm caudal	9721
the lesion epicenter , and one injection	9736
the lesion epicenter	9736
one injection	9762
each side 0.5 mm lateral to the cord midline	9779
each side 0.5 mm lateral	9779
the cord midline	9807
The glass micropipette	9825
the dorsal surface	9876
1 mm	9895
the spinal cord	9910
Each animal	9927
a total of 180,000 OECs	9948
a total	9948
180,000 OECs	9959
Another 15 rats	9973
four injections of an equal volume of vehicle alone -LRB- group DMEM -RRB-	9998
four injections	9998
an equal volume of vehicle alone -LRB- group DMEM -RRB-	10017
an equal volume	10017
vehicle alone -LRB- group DMEM -RRB-	10036
vehicle alone	10036
group DMEM	10051
The suspension	10064
a glass micropipette	10099
means	10123
20 msec pulses	10141
10 psi	10159
Picospitzer II , General Valve , Fairfield , NJ ; Verdú et al. , 2001 , 2003a	10167
Picospitzer II , General Valve	10167
Picospitzer II	10167
General Valve	10183
Fairfield , NJ ; Verdú et al.	10198
Fairfield , NJ	10198
Verdú et al.	10213
Verdú	10213
et al.	10219
2001 , 2003a	10227
2001	10227
2003a	10233
the wound	10250
the animals	10275
a warm environment	10300
full recovery	10325
Functional Evaluation Functional tests	10340
operation	10401
3 , 7 , and 14 days postoperation -LRB- dpo -RRB-	10418
3	10418
7	10421
14 days postoperation -LRB- dpo -RRB-	10428
14 days	10428
postoperation -LRB- dpo -RRB-	10436
postoperation	10436
dpo	10451
Locomotor activity	10457
the open-field walking scoring system	10496
the locomotor ability	10548
5 min	10577
One animal at a time	10584
One animal	10584
a time	10598
a circular plastic tray -LRB- 90 cm diameter 24 cm wall height -RRB-	10639
a circular plastic tray	10639
90 cm diameter 24 cm wall height	10664
90 cm diameter	10664
24 cm wall height	10681
Two independent examiners	10701
the hind-limb movements of the rat	10736
the hind-limb movements	10736
the rat	10763
the locomotor function	10783
the Basso , Beattie and Bresnahan scale	10819
Basso , Beattie and Bresnahan	10823
BBB scale	10859
Basso et al. , 1995	10870
Basso	10870
et al.	10876
1995	10884
The final score of each animal	10891
The final score	10891
each animal	10910
the mean value of both examiners	10926
the mean value	10926
both examiners	10944
The BBB scale	10960
0 -LRB- no hindlimb movement -RRB-	10986
0	10986
no hindlimb movement	10989
21 -LRB- normal movement-coordinated gait -RRB-	11014
21	11014
normal movement-coordinated gait	11018
Animals	11053
the inclined plane test -LRB- Rivlin and Tator , 1977 -RRB-	11084
the inclined plane test	11084
Rivlin and Tator , 1977	11109
Rivlin	11109
Tator , 1977	11120
Tator	11120
1977	11127
The maximum angle	11134
the animal	11161
a stable position	11187
5 sec on the inclined plane	11209
5 sec	11209
the inclined plane	11218
Nociceptive sensitivity	11251
a heat-radiation method	11292
a plantar algesimeter -LRB- Hargreaves et al. , 1988 -RRB-	11322
a plantar algesimeter	11322
Hargreaves	11345
et al. , 1988	11356
et al.	11356
1988	11364
The rat	11371
a plastic box	11395
an elevated glass floor	11414
the bottom of the box	11444
the bottom	11444
the box	11458
the light of a projection lamp -LRB- 150 W -RRB-	11467
the light	11467
a projection lamp -LRB- 150 W -RRB-	11480
a projection lamp	11480
150 W	11499
the plantar surface of the hindpaw	11532
the plantar surface	11532
the hindpaw	11555
The time to withdrawal of the heated paw -LRB- withdrawal latency -RRB-	11568
The time	11568
withdrawal of the heated paw -LRB- withdrawal latency -RRB-	11580
withdrawal	11580
the heated paw -LRB- withdrawal latency -RRB-	11594
the heated paw	11594
withdrawal latency	11610
a time-meter coupled with infrared detectors directed to the plantar surface	11651
a time-meter	11651
infrared detectors directed to the plantar surface	11677
infrared detectors	11677
the plantar surface	11708
The maximal time of stimulation	11729
The maximal time	11729
stimulation	11749
40 sec	11776
skin damage	11792
The value for a test	11805
The value	11805
a test	11819
the mean of three trials separated by 5 min resting periods	11830
the mean	11830
three trials separated by 5 min resting periods	11842
three trials	11842
5 min resting periods	11868
5 min	11868
periods	11882
Electrophysiological Evaluation Motor and somatosensory evoked potentials	11891
Electrophysiological Evaluation Motor	11891
somatosensory evoked potentials	11933
somatosensory	11933
potentials	11954
the integrity of spinal cord	11991
the integrity	11991
spinal cord	12008
tracts	12045
Animals	12053
sodium pentobarbital	12084
25 mg/kg , i.p.	12106
25 mg/kg	12106
a prone position	12137
a warmed flat coil	12159
a hot water circulating pump to maintain skin temperature above 32 °C	12192
a hot water	12192
pump	12216
skin temperature	12233
32 °C	12256
Motor	12262
potentials -LRB- MEPs -RRB-	12275
potentials	12275
MEPs	12287
monopolar needle electrodes	12313
the tibialis anterior muscle	12346
the contralateral sensorimotor cortex	12382
single rectangular pulses	12438
0.1 msec	12467
duration	12479
an intensity	12494
25 mA	12510
needle electrodes	12535
the cathode	12578
the skull overlying the sensorimotor cortex and the anode at the nose	12595
the skull	12595
the sensorimotor cortex and the anode	12615
the sensorimotor cortex	12615
the anode	12643
the nose	12656
This configuration	12666
transcranial stimulation	12694
subcortical efferent pathways	12734
Zappulla	12765
et al. , 1988 ; García-Alías et al. , 2003	12774
et al.	12774
1988 ; García-Alías et al.	12782
1988	12782
García-Alías et al.	12788
García-Alías	12788
et al.	12801
2003	12809
somatosensory evoked potentials -LRB- SSEPs -RRB-	12820
somatosensory	12820
potentials -LRB- SSEPs -RRB-	12841
potentials	12841
SSEPs	12853
electrical stimuli of 0.1 msec in duration and 4 mA intensity	12861
electrical stimuli	12861
0.1 msec in duration and 4 mA intensity	12883
0.1 msec	12883
duration and 4 mA intensity	12895
duration	12895
4 mA intensity	12908
5 Hz to the tibial nerve	12939
5 Hz	12939
the tibial nerve	12947
means of two needle electrodes inserted at the ankle	12967
means	12967
two needle electrodes inserted at the ankle	12976
two needle electrodes	12976
the ankle	13010
responses	13028
two needle electrodes	13058
the skull	13105
same sites as stimulation needles for MEPs	13116
same sites	13116
stimulation needles for MEPs	13130
stimulation needles	13130
MEPs	13154
A total of 256 responses	13161
A total	13161
256 responses	13172
100 msec following each stimulus	13207
100 msec	13207
each stimulus	13226
The signals	13255
the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude	13309
Sapphire 4ME	13327
Vickers	13341
the amplitude	13361
the latency of the evoked potentials -LRB- García-Alías et al. , 2003 -RRB-	13379
the latency	13379
the evoked potentials -LRB- García-Alías et al. , 2003 -RRB-	13394
the	13394
potentials -LRB- García-Alías et al. , 2003 -RRB-	13405
potentials	13405
García-Alías	13417
et al. , 2003	13430
et al.	13430
2003	13438
reproducibility	13455
the recording	13471
needles	13501
a microscope	13527
the same placement	13550
all animals guided by anatomical landmarks	13572
all animals	13572
anatomical landmarks	13594
Immunohistochemical Methods	13616
functional and electrophysiological tests	13650
3 , 7 , and 14 dpo	13696
3	13696
7	13699
14 dpo	13706
5 animals per group and day	13714
5 animals	13714
group and day	13728
4 % paraformaldehyde	13793
phosphate-buffer saline solution -LRB- PBS , 0.1 M , pH 7.4 -RRB-	13816
phosphate-buffer saline solution	13816
PBS	13850
0.1 M	13855
pH 7.4	13862
The spinal cord subjacent to T8 vertebra	13871
The spinal cord subjacent	13871
T8 vertebra	13900
the same solution for 24 h -LRB- lesion block -RRB-	13941
the same solution	13941
24 h -LRB- lesion block -RRB-	13963
24 h	13963
lesion block	13969
Segments of about 5 mm of spinal cord proximal and distal to the lesion block	13984
Segments	13984
5 mm of spinal cord proximal and distal to the lesion block	14002
5 mm	14002
spinal cord proximal and distal to the lesion block	14010
spinal cord	14010
the lesion block	14045
All spinal cord segments -LRB- proximal , lesion and distal blocks -RRB-	14100
All spinal cord segments	14100
proximal , lesion and distal blocks	14126
proximal	14126
lesion	14136
distal blocks	14147
PBS	14184
30 % sucrose	14199
4 °C	14225
Five intact control rats	14230
spinal cords subjacent to T7 , T8 and T9 vertebrae	14306
spinal cords	14306
T7 , T8 and T9 vertebrae	14332
group CNT	14379
Serial cryotome transverse sections 30 m thick from the spinal cord blocks	14391
Serial cryotome transverse sections	14391
30 m	14427
the spinal cord blocks	14444
trizma-buffer saline -LRB- TBS , 0.1 M , pH 7.4 -RRB-	14496
trizma-buffer saline	14496
TBS	14518
0.1 M	14523
pH 7.4	14529
0.5 % Triton-X-100 -LRB- Fluka , Madrid , Spain -RRB-	14542
0.5 % Triton-X-100	14542
Fluka	14561
Madrid	14568
Spain	14576
5 % FCS for 1 h	14587
5 % FCS	14587
1 h	14598
48 h	14623
4 °C	14631
rabbit anti-GFAP polyclonal antibody	14640
AB5040 ; 1:2000 , Chemicon	14678
AB5040	14678
1:2000 , Chemicon	14686
1:2000	14686
Chemicon	14694
mouse anti-COX-2 monoclonal antibody	14705
C-22420	14743
1:400 , Transduction Laboratories , Lexington , KY	14752
1:400	14752
Transduction Laboratories	14759
Lexington	14786
KY	14797
rabbit anti- VEGF	14802
sc-152	14821
1:100 , Santa Cruz Biotechnology , Santa Cruz , CA	14829
1:100	14829
Santa Cruz Biotechnology	14836
Santa Cruz	14862
CA	14874
tomato lectin -LRB- LEC ; L0651 ; 1:50 , Sigma -RRB-	14896
tomato lectin	14896
LEC ; L0651 ; 1:50 , Sigma	14911
LEC	14911
L0651 ; 1:50 , Sigma	14916
L0651	14916
1:50 , Sigma	14923
1:50	14923
Sigma	14929
washes	14943
sections	14951
secondary antiserum , donkey anti-rabbit or donkey antimouse Cy2	14980
secondary antiserum	14980
donkey anti-rabbit	15001
donkey antimouse Cy2	15023
Cy3	15047
immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch , West Grove , PA -RRB-	15059
immunoglobulin G	15059
1:200 , Jackson Immunoresearch , West Grove , PA	15077
1:200	15077
Jackson Immunoresearch	15084
West Grove	15108
PA	15120
Cy2 labeled avidin -LRB- 1:200 , Jackson Immunoresearch -RRB- overnight at 4 °C	15128
Cy2	15128
avidin -LRB- 1:200 , Jackson Immunoresearch -RRB-	15140
avidin	15140
1:200	15148
Jackson Immunoresearch	15155
overnight at 4 °C	15179
overnight	15179
4 °C	15192
additional washes	15207
sections	15226
gelatin-coated slides	15251
ethanol	15288
DPX -LRB- Fluka -RRB-	15313
DPX	15313
Fluka	15318
a control	15329
some spinal cord sections	15340
primary antibody	15389
Samples	15441
an Olympus BX-51 microscope	15467
epifluorescence	15509
appropriate filters	15531
Double-staining techniques	15552
the simultaneous visualization of COX-2 and microglial/macrophage cells	15593
the simultaneous visualization	15593
COX-2 and microglial/macrophage cells	15627
LEC labeled	15666
LEC	15666
astroglial cells -LRB- GFAP labeled -RRB-	15682
astroglial cells	15682
GFAP labeled	15700
GFAP	15700
Low power magnification -LRB- x4 -RRB- images of spinal cord sections	15715
Low power magnification -LRB- x4 -RRB- images	15715
x4	15740
spinal cord sections	15754
the aid	15791
a digital camera	15802
Olympus DP50	15820
the microscope	15846
NIH Image software	15880
Spinal cord sections stained for GFAP	15900
Spinal cord sections	15900
GFAP	15933
the area of preserved cord parenchyma	15962
the area	15962
preserved cord parenchyma	15974
high-intensity staining	16009
reactive astrocytes	16049
the destroyed parenchyma	16096
Two independent investigators	16122
these measurements	16157
the same images	16181
the final area of preserved cord parenchyma of each transverse sections analyzed	16198
the final area	16198
preserved cord parenchyma of each transverse sections analyzed	16216
preserved cord parenchyma	16216
each transverse sections analyzed	16245
each transverse sections	16245
the mean value of both subjects	16283
the mean value	16283
both subjects	16301
Eight to 10 transverse spinal cord sections per animal	16316
Eight	16316
10 transverse spinal cord sections per animal	16325
10 transverse spinal cord sections	16325
animal	16364
Verdú et al. , 2003a	16385
Verdú	16385
et al.	16391
2003a	16399
Spinal cord sections labeled against COX-2 and VEGF	16407
Spinal cord sections	16407
COX-2 and VEGF	16444
the COX-2 and VEGF staining	16483
the method described by Acarin et al. -LRB- 1997 -RRB-	16514
the method	16514
Acarin	16538
et al. -LRB- 1997 -RRB-	16545
et al.	16545
1997	16553
The quantitative measurement , referred to as the `` reactivity grade , ''	16560
The quantitative measurement	16560
as the `` reactivity grade , ''	16602
the ratio between immunolabeling density	16644
the ratio	16644
immunolabeling density	16662
spinal cord sections	16688
lesioned animals -LRB- OEC and DMEM groups -RRB-	16712
lesioned animals	16712
OEC and DMEM groups	16730
OEC	16730
DMEM groups	16738
spinal cord sections of unlesioned rats -LRB- CNT group -RRB-	16758
spinal cord sections	16758
unlesioned rats -LRB- CNT group -RRB-	16782
unlesioned rats	16782
CNT group	16799
-LRB- math	16834
equation -RRB- A reactive grade -LRB- mean of three random sections -RRB-	16841
equation	16841
A reactive grade -LRB- mean of three random sections -RRB-	16851
A reactive grade	16851
mean of three random sections	16869
mean	16869
three random sections	16877
COX-2	16917
VEGF in each spinal cord block	16931
VEGF	16931
each spinal cord block	16939
Whole spinal cord transverse sections	16963
these measurements	17015
variability	17054
all sections	17067
each marker and spinal block	17097
each marker	17097
spinal block	17113
lesioned and control animals	17131
The setting for image acquisition	17191
The setting	17191
image acquisition	17207
the same for all the images	17229
the same	17229
all the images	17242
Spinal cord sections	17258
LEC	17292
stains microglia and blood vessels -LRB- Acarin et al. , 1994 -RRB-	17302
stains microglia and blood vessels	17302
Acarin	17338
et al. , 1994	17345
et al.	17345
1994	17353
the number of blood vessel profiles	17383
the number	17383
blood vessel profiles	17397
the grey matter of ventral horns	17422
the grey matter	17422
ventral horns	17441
A grid of 0.04 mm2 -LRB- representing more than 97 % of the horn at x50 -RRB-	17456
A grid of 0.04 mm2	17456
A grid	17456
0.04 mm2	17466
more than 97 % of the horn at x50	17489
more than 97 %	17489
the horn at x50	17506
the horn	17506
x50	17518
each ventral horn and all blood vessel profiles	17538
each ventral horn	17538
all blood vessel profiles	17560
the grid counted	17593
the grid	17593
At least five random sections of proximal , lesion , and distal spinal cord	17611
At least five random sections	17611
proximal , lesion , and distal spinal cord	17644
proximal	17644
lesion	17654
distal spinal cord	17666
animal	17696
The density of blood vessel profiles -LRB- number / mm2 -RRB-	17717
The density of blood vessel profiles	17717
The density	17717
blood vessel profiles	17732
mm2	17763
these counts	17788
Statistical Analysis All	17802
Statistical Analysis	17802
All	17823
functional , electrophysiological and histological measurements	17827
a `` blinded '' manner	17908
a code	17934
rats and histological slices	17944
rats	17944
histological slices	17953
Data	17974
the mean ± SEM	17992
Statistical comparisons between groups	18008
Statistical comparisons	18008
groups	18040
nonparametric Kruskal-Wallis and Mann-Whitney U-tests	18060
nonparametric Kruskal-Wallis	18060
Mann-Whitney U-tests	18093
Differences	18115
p	18158
The relationships between results of different tests	18168
The relationships	18168
results of different tests	18194
results	18194
different tests	18205
lineal regression	18241
The experimental procedures	18260
the recommendations of the European Union and the U.S. Department of Health	18299
the recommendations of the European Union	18299
the recommendations	18299
the European Union	18322
the U.S. Department of Health	18345
the U.S. Department	18345
Health	18368
the care and use of laboratory animals	18379
the care and use	18379
laboratory animals	18399
the Ethics Committee of our institution	18439
the Ethics Committee	18439
our institution	18463
RESULTS	18481
1	18495
AREA	18498
SPINAL CORD PARENCHYMA -LRB- MM2 -RRB-	18516
SPINAL CORD PARENCHYMA	18516
MM2	18540
PROXIMAL , LESION AND DISTAL SPINAL CORD	18550
PROXIMAL	18550
LESION	18560
DISTAL SPINAL CORD	18571
3 , 7 , AND 14 DAYS POSTOPERATION -LRB- DPO -RRB- TABLE 2	18600
3 , 7	18600
3	18600
7	18603
14 DAYS POSTOPERATION -LRB- DPO -RRB- TABLE 2	18610
14 DAYS	18610
POSTOPERATION -LRB- DPO -RRB- TABLE 2	18618
POSTOPERATION	18618
DPO	18633
TABLE 2	18639
RESULTS OF REGRESSION ANALYSIS OF SEVERAL FUNCTIONAL AND HISTOLOGICAL PARAMETERS	18648
RESULTS	18648
REGRESSION ANALYSIS OF SEVERAL FUNCTIONAL AND HISTOLOGICAL PARAMETERS	18659
REGRESSION ANALYSIS	18659
SEVERAL FUNCTIONAL AND HISTOLOGICAL PARAMETERS	18682
SEVERAL	18682
FUNCTIONAL AND HISTOLOGICAL PARAMETERS	18690
FUNCTIONAL	18690
HISTOLOGICAL PARAMETERS	18705
1	18735
Histogram representation	18738
the locomotor activity	18766
the BBB-score -LRB- A -RRB- , and the time to withdrawal	18802
the BBB-score -LRB- A -RRB-	18802
the BBB-score	18802
A	18817
the time to withdrawal	18825
the time	18825
withdrawal	18837
the heated paw	18851
the plantar algesimetry test -LRB- B -RRB-	18869
the plantar algesimetry test	18869
B	18899
time	18907
DMEM -LRB- open columns -RRB-	18915
DMEM	18915
open columns	18921
OEC -LRB- filled columns -RRB- experimental groups	18939
OEC -LRB- filled columns -RRB-	18939
OEC	18939
columns	18951
experimental groups	18960
p < 0.01 -LRB- ** -RRB- versus DMEM group .	18981
p	18981
< 0.01 -LRB- ** -RRB-	18983
<	18983
0.01 -LRB- ** -RRB-	18985
0.01	18985
DMEM group	19002
Columns	19014
the mean , and error bars the SEM	19026
the mean	19026
error bars the SEM	19040
error bars	19040
the SEM	19051
FIG. 2 .	19061
FIG.	19061
2	19066
Representative recordings of motor	19069
Representative recordings	19069
motor	19098
potentials -LRB- MEPs , left panels -RRB- and somatosensory	19111
potentials -LRB- MEPs , left panels -RRB-	19111
potentials	19111
MEPs , left panels	19123
MEPs	19123
panels	19134
somatosensory	19146
potentials -LRB- SSEPs , right panels -RRB-	19167
potentials	19167
SSEPs , right panels	19179
SSEPs	19179
right panels	19186
intact control rats -LRB- A , B -RRB-	19203
intact control rats	19203
A , B	19224
A	19224
B	19226
rats	19236
group DMEM	19244
group OEC	19273
E , F , I , J , M , N	19284
E	19284
F	19286
I	19288
J	19290
M	19292
N	19294
surgery -LRB- A , B -RRB-	19304
surgery	19304
A , B	19313
A	19313
B	19315
3 dpo -LRB- C -- F -RRB-	19322
C -- F	19329
C	19329
F	19331
7 dpo -LRB- G -- J -RRB-	19335
G -- J	19342
G	19342
J	19344
14 dpo -LRB- K -- N -RRB-	19352
K -- N	19360
K	19360
N	19362
Horizontal scale	19366
= 5 msec and vertical scale	19383
= 5 msec	19383
5	19385
vertical scale	19396
= 5 mV for all MEP recordings ; horizontal scale = 10	19411
= 5 mV for all MEP recordings	19411
= 5 mV	19411
5	19413
all MEP recordings	19422
horizontal scale = 10	19442
horizontal scale	19442
10	19461
msec and vertical scale	19464
msec	19464
vertical scale	19473
= 4 µV for all SSEP recordings	19488
= 4 µV	19488
4	19490
all SSEP recordings	19499
FIG. 3 .	19521
FIG.	19521
3	19526
Histogram representation of the amplitude of the motor	19529
Histogram representation	19529
the amplitude of the motor	19557
the amplitude	19557
the motor	19574
potentials -LRB- MEPs -RRB-	19591
potentials	19591
MEPs	19603
the tibialis anterior muscle -LRB- A -RRB-	19621
the tibialis anterior muscle	19621
A	19651
the amplitudes of the N1 -LRB- B -RRB-	19659
the amplitudes	19659
the N1 -LRB- B -RRB-	19677
the N1	19677
B	19685
N2 -LRB- C -RRB-	19689
N2	19689
C	19693
N3	19701
D	19705
waves of somatosensory	19708
waves	19708
somatosensory	19717
potentials -LRB- SSEPs -RRB-	19738
potentials	19738
SSEPs	19750
time	19762
DMEM -LRB- open column -RRB- and OEC	19771
DMEM -LRB- open column -RRB-	19771
DMEM	19771
open column	19777
OEC	19794
column	19806
groups	19814
p 0.05 -LRB- * -RRB- versus DMEM group	19822
p 0.05 -LRB- * -RRB-	19822
p 0.05	19822
DMEM group	19842
p < 0.01 -LRB- ** -RRB- versus DMEM group	19854
p < 0.01 -LRB- ** -RRB-	19854
p < 0.01	19854
p <	19854
p	19854
0.01	19858
DMEM group	19875
Columns	19887
the mean , and error bars the SEM	19899
the mean	19899
error bars the SEM	19913
error bars	19913
the SEM	19924
FIG. 4 .	19934
FIG.	19934
4	19939
Spinal cord sections	19942
COX-2 -LRB- A -- F -RRB- and VEGF -LRB- G -- L -RRB-	19981
COX-2	19981
A -- F	19988
A	19988
F	19990
VEGF	19997
G -- L	20003
G	20003
L	20005
the lesion site segment	20017
DMEM -LRB- A -- C , G -- I -RRB- and OEC -LRB- D -- F , J -- L -RRB- groups ,	20046
DMEM	20046
A -- C , G --	20052
A	20052
C , G	20054
C	20054
G	20056
I	20058
OEC -LRB- D -- F , J -- L -RRB- groups	20065
OEC	20065
D -- F	20070
D	20070
F	20072
J -- L	20075
J	20075
L	20077
groups	20080
3 dpo -LRB- left -RRB- , 7 dpo -LRB- middle -RRB- , and 14 dpo -LRB- right -RRB-	20091
3 dpo -LRB- left -RRB-	20091
left	20098
7 dpo -LRB- middle -RRB-	20105
middle	20112
14 dpo -LRB- right -RRB-	20125
right	20133
Images of blood vessel profiles	20141
Images	20141
blood vessel profiles	20151
lectin in the gray matter of DMEM -LRB- M -RRB- and OEC -LRB- N -RRB- groups	20186
lectin	20186
the gray matter of DMEM -LRB- M -RRB- and OEC -LRB- N -RRB- groups	20196
the gray matter of DMEM -LRB- M -RRB-	20196
the gray matter	20196
DMEM -LRB- M -RRB-	20215
DMEM	20215
M	20221
OEC -LRB- N -RRB- groups	20228
OEC	20228
N	20233
groups	20236
Images	20244
the mean changes in each group	20273
the mean changes	20273
each group	20293
Bar	20305
1000 µm -LRB- A -- L -RRB- , 50 µm -LRB- M , N -RRB-	20311
1000 µm -LRB- A -- L -RRB-	20311
A -- L	20320
A	20320
L	20322
50 µm -LRB- M , N -RRB-	20326
FIG. 5 .	20340
FIG.	20340
5	20345
Histogram representation of COX-2 and VEGF	20348
Histogram representation	20348
COX-2 and VEGF	20376
quantification	20402
time in transversal spinal cord sections of DMEM -LRB- open column -RRB- and OEC	20422
time	20422
transversal spinal cord sections of DMEM -LRB- open column -RRB- and OEC	20430
transversal spinal cord sections	20430
DMEM -LRB- open column -RRB- and OEC	20466
DMEM -LRB- open column -RRB-	20466
DMEM	20466
open column	20472
OEC	20489
column	20501
groups from proximal -LRB- top -RRB- and lesion -LRB- bottom -RRB-	20509
groups	20509
proximal -LRB- top -RRB- and lesion -LRB- bottom -RRB-	20521
proximal	20521
top	20531
lesion	20540
bottom	20548
spinal cord blocks	20556
p <	20577
p	20577
<	20579
0.05 versus DMEM group .	20581
0.05	20581
DMEM group .	20593
DMEM	20593
Columns	20605
the mean and error bars	20617
the SEM	20641
FIG. 6 .	20651
FIG.	20651
6	20656
Double staining for COX-2	20659
Double staining	20659
COX-2	20679
LEC -LRB- red/green -RRB- immunoreactivity in DMEM -LRB- A -RRB-	20685
LEC -LRB- red/green -RRB- immunoreactivity	20685
LEC -LRB- red/green -RRB-	20685
LEC	20685
red/green	20690
DMEM -LRB- A -RRB-	20721
DMEM	20721
A	20727
OEC -LRB- B -RRB- groups	20734
OEC	20734
B	20739
groups	20742
COX	20758
2/GFAP -LRB- red/green -RRB- immunoreactivity	20763
2/GFAP -LRB- red/green -RRB-	20763
2/GFAP	20763
red/green	20771
DMEM -LRB- C -RRB- and OEC -LRB- D -RRB-	20802
DMEM	20802
C	20808
OEC	20815
D	20820
groups	20823
the lesion border	20836
Yellow-orange labeling	20855
colocalization	20888
Bar	20904
50 µm	20910
Functional Results	20918
the spinal cord	20954
all animals	20971
normal locomotor behavior -LRB- score 21 -RRB-	20990
normal locomotor behavior	20990
score 21	21017
3 dpo	21031
the BBB-score	21038
values of 10	21070
values	21070
10	21080
group DMEM and 16	21086
group DMEM	21086
16	21101
group OEC	21107
The BBB-score	21118
mean values of 12 and 18 at 7 dpo	21159
mean values	21159
12 and 18	21174
7 dpo	21187
13 and 20 at 14 dpo in DMEM and OEC groups , respectively -LRB- Fig. 1A -RRB-	21198
13 and 20	21198
14 dpo in DMEM and OEC groups , respectively -LRB- Fig. 1A -RRB-	21211
14 dpo in DMEM and OEC groups , respectively	21211
14 dpo in DMEM and OEC groups	21211
14 dpo	21211
DMEM and OEC groups	21221
Fig. 1A	21256
The OEC group	21266
significantly higher scores	21284
group DMEM	21317
all postlesion times	21331
The preoperative mean values of the maximum angle in the inclined plane	21353
The preoperative mean values	21353
the maximum angle in the inclined plane	21385
the maximum angle	21385
the inclined plane	21406
about 48 °	21430
3 dpo	21444
the mean maximum angle	21451
37 °	21487
41 ° in DMEM and OEC rats , then	21495
41 °	21495
DMEM and OEC rats , then	21502
DMEM and OEC rats	21502
mean values of 41 ° and 48 ° in DMEM and OEC groups	21559
mean values of 41 °	21559
mean values	21559
41 °	21574
48 ° in DMEM and OEC groups	21582
48 °	21582
DMEM and OEC groups	21589
14 dpo	21612
all postoperative days	21627
the mean maximum angle	21651
OEC	21702
DMEM animals	21714
p < 0.05	21728
p	21728
< 0.05	21730
<	21730
0.05	21732
Nociceptive withdrawal responses evaluated by plantar algesimetry	21739
Nociceptive withdrawal responses	21739
plantar algesimetry	21785
a latency of about 9 sec	21809
a latency	21809
9 sec	21828
lesion	21841
spinal cord lesion	21855
the mean time of withdrawal of the heated paw	21875
the mean time	21875
withdrawal of the heated paw	21892
withdrawal	21892
the heated paw	21906
7 dpo to 22 and 14 sec in DMEM and OEC groups	21934
7 dpo to 22	21934
7 dpo	21934
22	21943
14 sec in DMEM and OEC groups	21950
14 sec	21950
DMEM and OEC groups	21960
then	21995
group DMEM	22013
18 seconds	22027
group OEC	22061
The withdrawal latency	22072
OEC	22122
DMEM animals	22134
follow-up -LRB- Fig. 1B -RRB-	22154
follow-up	22154
Fig. 1B	22165
Electrophysiological Results MEPs recorded prior to operation	22175
Electrophysiological Results MEPs	22175
operation	22227
a single wave	22244
a mean latency of about 6 msec	22263
a mean latency	22263
6 msec	22287
amplitude of about 15 mV	22303
amplitude	22303
about 15 mV	22316
both groups -LRB- Fig. 2 -RRB-	22331
both groups	22331
Fig. 2	22344
photochemical injury	22359
no changes in the latency	22381
no changes	22381
the latency	22395
follow-up	22428
the amplitude	22443
both groups	22479
3 dpo	22494
10 and 15 mV	22542
DMEM and OEC groups , respectively at 14 dpo ,	22558
DMEM and OEC groups	22558
14 dpo	22595
significant differences in favor of group OEC at 7 and 14	22608
significant differences	22608
favor of group OEC at 7 and 14	22635
favor	22635
group OEC at 7 and 14	22644
group OEC	22644
7 and 14	22657
Figs. 2 and 3	22671
Figs. 2	22671
3	22683
Control SSEPs	22687
a series	22708
negative peaks	22733
latencies of 14 , 20 , and 29 msec	22751
latencies	22751
14 , 20 , and 29 msec	22764
14	22764
20	22768
29 msec	22776
N1 , N2 , and N3 waves	22794
mean amplitudes of 9 , 16 , and 14 µV , respectively -LRB- Fig. 2 -RRB-	22821
mean amplitudes	22821
9 , 16 , and 14 µV , respectively -LRB- Fig. 2 -RRB-	22840
9 , 16 , and 14 µV , respectively	22840
9 , 16 , and 14	22840
µV	22854
Fig. 2	22872
spinal cord injury	22887
the amplitude of the three waves	22907
the amplitude	22907
the three waves	22924
group OEC	22968
group DMEM at all postoperative test days -LRB- Figs. 2 and 3 -RRB-	22986
group DMEM	22986
all postoperative test days -LRB- Figs. 2 and 3 -RRB-	23000
all postoperative test days	23000
Figs. 2 and 3	23029
Figs. 2	23029
3	23041
Histological Results	23045
group DMEM	23069
transverse spinal cord sections from T8 spinal cord segment	23081
transverse spinal cord sections	23081
T8 spinal cord segment	23118
lesion block	23142
a cavity affecting the dorsal	23163
a cavity	23163
the dorsal	23182
the central canal	23209
parenchyma partially involving the lateral funiculi	23238
parenchyma	23238
the lateral funiculi	23269
14 dpo -LRB- Fig. 4 -RRB-	23302
14 dpo	23302
Fig. 4	23310
3 dpo	23322
group OEC	23332
spinal cord sections from the lesion level	23343
spinal cord sections	23343
the lesion level	23369
a smaller cavity	23393
only the dorsal funiculus	23420
7 and 14 dpo	23455
7	23455
14 dpo	23461
dorsolateral areas -LRB- Fig. 4 -RRB-	23482
dorsolateral areas	23482
Fig. 4	23502
14 dpo	23514
5 of 5 DMEM rats	23525
5	23525
5 DMEM rats	23530
3 of 5 OEC rats	23549
3	23549
5 OEC rats	23554
sections from proximal and distal blocks	23566
sections	23566
proximal and distal blocks	23580
parenchyma in the dorsal funiculus	23624
parenchyma	23624
the dorsal funiculus	23638
The average area of preserved spinal cord	23660
The average area	23660
preserved spinal cord	23680
3 to 14 dpo	23717
experimental groups	23737
the three spinal levels studied	23760
the three spinal levels	23760
The area of preserved spinal cord	23793
The area	23793
preserved spinal cord	23805
group OEC	23855
group DMEM	23873
the three intervals evaluated -LRB- Table 1 -RRB-	23887
the three intervals	23887
Table 1	23918
COX-2 immunoreactivity .	23928
COX-2	23928
immunoreactivity	23934
COX-2 staining	23952
spinal cord sections from lesioned rats with respect	23980
spinal cord sections	23980
lesioned rats with respect	24006
lesioned rats	24006
respect	24025
rats	24044
group DMEM	24053
at 3 and 7 dpo sections from the T8 spinal cord segment	24065
at 3 and 7 dpo sections	24065
the T8 spinal cord segment	24094
intense COX	24128
2 staining in spinal parenchyma	24141
2 staining	24141
spinal parenchyma	24155
the cavity -LRB- Fig. 4A , B -RRB-	24185
the cavity	24185
Fig. 4A , B	24197
Fig. 4A	24197
B	24205
3 dpo	24212
sections of group OEC	24222
sections	24222
group OEC	24234
COX - 2 staining	24245
COX	24245
2 staining	24250
spinal cord parenchyma	24277
the cavity , and spread to ventral grey matter	24312
the cavity , and spread	24312
ventral grey matter	24338
white matter of lateral and ventral funiculi -LRB- Fig. 4D -RRB-	24362
white matter	24362
lateral and ventral funiculi -LRB- Fig. 4D -RRB-	24378
lateral and ventral funiculi	24378
Fig. 4D	24408
7 dpo	24421
COX-2 staining	24428
the spinal cord parenchyma around the cavity	24462
the spinal cord parenchyma	24462
the cavity	24496
the tissue filling the cavity -LRB- Fig. 4E -RRB-	24514
the tissue	24514
the cavity -LRB- Fig. 4E -RRB-	24533
the cavity	24533
Fig. 4E	24545
14 dpo	24558
lower COX-2 staining	24566
lower COX-2	24566
staining	24578
the tissue that filled the cavity	24603
the tissue	24603
the cavity	24626
the cord parenchyma in both groups -LRB- Fig. 4C , F -RRB-	24649
the cord parenchyma	24649
both groups -LRB- Fig. 4C , F -RRB-	24672
both groups	24672
Fig. 4C , F	24685
Fig. 4C	24685
F	24693
the lesion block	24700
the mean COX-2 reactivity grade at 3 dpo	24718
the mean COX-2 reactivity grade	24718
3 dpo	24753
about 4 and 8	24763
DMEM and OEC groups	24780
both groups	24847
1.5 at 14 dpo	24868
1.5	24868
14 dpo	24875
The COX-2 reactivity grade	24883
OEC	24938
DMEM group	24950
3 and 7 dpo -LRB- Fig. 5 -RRB-	24964
3 and 7 dpo	24964
Fig. 5	24977
spinal cord sections from the proximal block	24989
spinal cord sections	24989
the proximal block	25015
the COX-2 reactivity grade	25035
3 and 5	25077
DMEM and OEC groups -LRB- p < 0.05 -RRB-	25088
DMEM and OEC groups	25088
p < 0.05	25109
p	25109
< 0.05	25111
<	25111
0.05	25113
3 dpo	25137
3	25167
7 dpo and 2	25172
7 dpo	25172
2	25182
14 dpo in both groups	25187
14 dpo	25187
both groups	25197
the distal block sections	25213
the COX-2 reactivity grade	25240
6 and 5	25276
DMEM and OEC groups	25287
3 dpo	25325
group DMEM	25343
the COX-2 reactivity grade	25354
2	25394
14 dpo	25399
group OEC	25410
it	25420
7	25436
7 dpo	25441
Significant differences	25468
DMEM and OEC groups	25511
7 dpo -LRB- Fig. 5 -RRB-	25534
7 dpo	25534
Fig. 5	25541
Double staining COX-2	25550
Double staining	25550
COX-2	25566
GFAP and COX-2	25572
GFAP	25572
COX-2	25581
LEC	25587
Double staining for COX-2 and GFAP	25592
Double staining	25592
COX-2 and GFAP	25612
3 dpo	25649
sections of group DMEM	25659
sections	25659
group DMEM	25671
very few cells	25683
COX-2 and GFAP	25715
contrast	25734
OEC rats	25747
areas of COX-2 -- and GFAP-positive parenchyma	25757
areas	25757
COX-2 -- and GFAP-positive parenchyma	25766
COX-2	25766
GFAP-positive parenchyma	25777
Fig. 6C , D	25822
Fig. 6C	25822
D	25830
Double labeling against COX-2 and LEC	25834
Double labeling	25834
COX-2 and LEC	25858
overlapping of both markers	25884
overlapping	25884
both markers	25899
spinal cord sections in group DMEM	25931
spinal cord sections	25931
group DMEM	25955
group OEC -LRB- Fig. 6A , B -RRB-	25974
group OEC	25974
Fig. 6A , B	25985
Fig. 6A	25985
B	25993
7 dpo	26000
sections of group DMEM	26010
sections	26010
group DMEM	26022
COX-2 staining	26034
LEC-positive round cells	26077
sections from group OEC	26114
sections	26114
group OEC	26128
COX-2 staining	26139
GFAP-positive cells	26166
LEC-positive cells that filled and surrounded the cavity	26198
LEC-positive cells	26198
the cavity	26244
14 dpo	26259
both experimental groups	26270
COX-2 staining	26296
LEC-positive cells in the cavity	26332
LEC-positive cells	26332
the cavity	26354
The same temporal pattern	26366
spinal cord sections	26408
proximal and distal blocks	26434
VEGF immunoreactivity .	26462
VEGF	26462
immunoreactivity	26467
VEGF staining	26485
spinal cord sections	26521
lesioned rats with respect	26547
lesioned rats	26547
respect	26566
unoperated animals	26577
3 dpo	26600
sections from the lesion block of both groups	26610
sections	26610
the lesion block of both groups	26624
the lesion block	26624
both groups	26644
VEGF-immunoreactivity	26657
all the spinal cord parenchyma	26695
grey and white matter -LRB- Fig. 4G , J -RRB-	26737
grey and white matter	26737
Fig. 4G , J	26760
Fig. 4G	26760
J	26768
7 dpo	26775
the levels of VEGF staining	26782
the levels	26782
VEGF staining	26796
group DMEM -LRB- Fig. 4H -RRB-	26823
group DMEM	26823
Fig. 4H	26835
group OEC -LRB- Fig. 4K -RRB-	26861
group OEC	26861
Fig. 4K	26872
significantly higher reactivity grade -LRB- Fig. 5 -RRB-	26886
significantly higher reactivity grade	26886
Fig. 5	26925
the grey matter	26949
higher VEGF staining	26972
the white matter	26998
14 dpo	27019
VEGF staining	27027
both groups -LRB- Fig. 4I , L -RRB-	27056
both groups	27056
Fig. 4I , L	27069
Fig. 4I	27069
L	27077
spinal cord sections from the proximal block	27084
spinal cord sections	27084
the proximal block	27110
the mean VEGF reactivity grade	27130
time postinjury	27190
3 and 7 dpo in group OEC	27239
3 and 7 dpo	27239
group OEC	27254
group DMEM -LRB- Fig. 5 -RRB-	27272
group DMEM	27272
Fig. 5	27284
The VEGF reactivity grade	27293
sections	27341
the distal block	27361
group OEC	27407
7 dpo with respect	27425
7 dpo	27425
respect	27436
group DMEM	27447
Density of blood vessels .	27459
Density	27459
blood vessels	27470
spinal cord sections subjacent to T8 vertebra from unlesioned rats	27488
spinal cord sections	27488
T8 vertebra from unlesioned rats	27522
T8 vertebra	27522
unlesioned rats	27539
the average density of blood vessel profiles	27556
the average density	27556
blood vessel profiles	27579
515 ± 21 blood vessels / mm2	27605
515 ± 21 blood vessels	27605
515	27605
21 blood vessels	27611
mm2	27629
The density of blood vessel profiles	27634
The density	27634
blood vessel profiles	27649
378	27675
17 in group DMEM and 369 ± 9 blood vessels/mm2	27681
17 in group DMEM	27681
17	27681
group DMEM	27687
369 ± 9 blood vessels/mm2	27702
369	27702
9 blood vessels/mm2	27708
group OEC at 3 dpo	27731
group OEC	27731
3 dpo	27744
It	27751
491 ±	27778
43 and 604 ± 27	27784
43 and 604	27784
27	27797
7 dpo	27803
512 ±	27816
25 and 687 ± 32 blood vessels/mm2	27822
25 and 687	27822
32 blood vessels/mm2	27835
14 dpo in groups DMEM and OEC	27859
14 dpo	27859
groups DMEM and OEC	27869
The mean density of blood vessel profiles	27904
The mean density	27904
blood vessel profiles	27924
group OEC	27974
group DMEM	27992
7 -LRB- p < 0.05 -RRB- and 14 dpo -LRB- p < 0.01 -RRB- -LRB- Fig. 4 -RRB-	28006
7 -LRB- p < 0.05 -RRB-	28006
7	28006
p < 0.05	28009
p	28009
< 0.05	28011
<	28011
0.05	28013
14 dpo -LRB- p < 0.01 -RRB- -LRB- Fig. 4 -RRB-	28023
14 dpo -LRB- p < 0.01 -RRB-	28023
p < 0.01	28031
p	28031
< 0.01	28033
<	28033
0.01	28034
Fig. 4	28041
spinal cord sections subjacent to T7 vertebra from control rats	28053
spinal cord sections	28053
T7 vertebra from control rats	28087
T7 vertebra	28087
control rats	28104
the density of blood vessel profiles	28118
the density	28118
blood vessel profiles	28133
512	28164
13 blood vessels/mm2	28170
spinal cord sections from proximal cord blocks	28195
spinal cord sections	28195
proximal cord blocks	28221
the density	28243
410 ± 14 and 389 ± 26 blood vessels/mm2 at 3 dpo in groups DMEM and OEC	28259
410 ± 14 and 389	28259
410	28259
14 and 389	28265
26 blood vessels/mm2 at 3 dpo in groups DMEM and OEC	28278
26 blood vessels/mm2	28278
3 dpo in groups DMEM and OEC	28302
3 dpo	28302
groups DMEM and OEC	28311
It	28346
487 ± 41 and 533	28362
18 at 7 dpo , and to 559 ± 19 and 665 ± 26 -LRB- p < 0.01 -RRB-	28381
18	28381
7 dpo	28387
559 ±	28401
19 and 665 ± 26 -LRB- p < 0.01 -RRB-	28407
19 and 665 ± 26	28407
19 and 665	28407
26	28420
p < 0.01	28424
p	28424
< 0.01	28426
<	28426
0.01	28428
blood vessels/mm2	28434
14 dpo in groups DMEM and OEC	28455
14 dpo	28455
groups DMEM and OEC	28465
spinal cord subjacent to T9 vertebra from unlesioned rats	28503
spinal cord subjacent	28503
T9 vertebra from unlesioned rats	28528
T9 vertebra	28528
unlesioned rats	28545
the density of blood vessels	28561
the density	28561
blood vessels	28576
517 ± 4 blood vessels/mm2	28594
517	28594
4 blood vessels/mm2	28600
the distal block sections of injured rats	28624
the distal block sections	28624
injured rats	28653
the density	28666
400 ± 14 and 427	28682
400	28682
14 and 427	28688
10 blood vessels/mm2	28701
3 dpo , 470 ± 32 and 532	28725
3 dpo	28725
470 ± 32 and 532	28732
470	28732
32 and 532	28738
20 blood vessels/mm2 at 7 dpo , and 590 ± 14	28751
20 blood vessels/mm2	28751
7 dpo , and 590 ± 14	28775
7 dpo	28775
590 ± 14	28786
590	28786
14	28792
666 ± 15 -LRB- p < 0.01 -RRB-	28799
666 ± 15	28799
666	28799
15	28805
p < 0.01	28809
p	28809
< 0.01	28811
<	28811
0.01	28813
blood vessels/mm2 at 14 dpo in groups DMEM and OEC	28819
blood vessels/mm2	28819
14 dpo in groups DMEM and OEC	28840
14 dpo	28840
groups DMEM and OEC	28850
Functional and histological correlations .	28885
Functional and histological correlations	28885
Functional	28885
histological correlations	28900
Table 2	28927
the results of the regression analysis of functional and histological parameters	28941
the results	28941
the regression analysis of functional and histological parameters	28956
the regression analysis	28956
functional and histological parameters	28983
a biochemical chain reaction	29026
the COX-2 reactivity grade seen at 3 dpo	29056
the COX-2 reactivity grade	29056
3 dpo	29091
the VEGF reactivity grade	29131
7 dpo	29160
this VEGF reactivity grade	29171
the density of blood vessel profiles	29237
the density	29237
blood vessel profiles	29252
14 dpo	29277
DISCUSSION The results of this study	29286
DISCUSSION The results	29286
DISCUSSION	29286
The results	29297
this study	29312
the lesion site	29337
the reactivity of COX-2 and VEGF	29354
the reactivity	29354
COX-2 and VEGF	29372
spinal cord sections in OEC-transplanted	29418
spinal cord sections	29418
OEC-transplanted	29442
DMEM-injected rats during the first week postlesion	29473
DMEM-injected rats	29473
the first week postlesion	29499
addition	29529
the density of blood vessel profiles in the ventral gray matter	29539
the density	29539
blood vessel profiles in the ventral gray matter	29554
blood vessel profiles	29554
the ventral gray matter	29579
spinal cord sections	29631
group OEC	29657
group DMEM	29677
accordance with previous studies	29692
accordance	29692
previous studies	29708
the photochemical injury	29726
the dorsal	29760
dosolateral funiculi of the spinal cord -LRB- Verdú et al. , 2003b -RRB-	29775
dosolateral funiculi	29775
the spinal cord -LRB- Verdú et al. , 2003b -RRB-	29799
the spinal cord	29799
Verdú	29816
et al. , 2003b	29822
et al.	29822
2003b	29830
the area of preserved cord parenchyma	29842
the area	29842
preserved cord parenchyma	29854
OEC transplantation -LRB- Verdú et al. , 2003a -RRB-	29911
OEC transplantation	29911
Verdú	29932
et al. , 2003a	29938
et al.	29938
2003a	29946
comparison with rats that received an injection of medium	29957
comparison	29957
rats that received an injection of medium	29973
rats	29973
an injection of medium	29992
an injection	29992
medium	30008
OEC-transplanted rats	30016
better locomotor function	30045
normal nociceptive responses	30085
the electrophysiological results	30123
the amplitude of motor and somatosensory	30171
the amplitude	30171
motor and somatosensory	30188
potentials	30219
OECs	30258
DMEM-injected rats	30272
evidence of functional preservation of descending and ascending spinal pathways	30302
evidence	30302
functional preservation of descending and ascending spinal pathways	30314
functional preservation	30314
spinal pathways	30366
Spontaneous recovery of the functional loss	30383
Spontaneous recovery	30383
the functional loss	30407
experimental animals or humans	30461
the early days or weeks	30500
partial spinal cord injuries -LRB- Tator , 1998 -RRB-	30530
partial spinal cord injuries	30530
Tator	30560
1998	30567
Several mechanisms	30574
such recovery	30608
especially reduction of edema and hematomyelia	30623
especially reduction	30623
edema and hematomyelia	30647
the resolution of the primary and secondary injury insults	30674
the resolution	30674
the primary and secondary injury insults	30692
Little et al. , 1999	30734
Little	30734
et al.	30741
1999	30749
The progressive decrease of the spinal cord tissue area	30756
The progressive decrease	30756
the spinal cord tissue area	30784
the functional recovery	30825
the first two weeks	30865
injury in the present study	30891
injury	30891
the present study	30901
the reduction of edema	30942
the reduction	30942
edema	30959
OEC-transplanted rats	30980
a better neurological and electrophysiological recovery	31006
smaller cord tissue loss than DMEM-injected rats	31070
smaller cord tissue loss	31070
DMEM-injected rats	31100
The photochemical	31120
lesion	31146
the spinal dorsal columns	31162
animals of the OEC group	31191
animals	31191
the OEC group	31202
the lateral funiculi in the DMEM-injected rats	31235
the lateral funiculi	31235
the DMEM-injected rats	31259
This reduction in the extent of the lesion	31283
This reduction	31283
the extent of the lesion	31301
the extent	31301
the lesion	31315
the considerably improved functional and electrophysiological outcome	31338
rats with OEC transplant	31411
rats	31411
OEC transplant	31421
Spinal cord injuries	31437
localized within the dorsal columns	31470
the dorsal	31487
mild functional motor deficits	31514
lesions affecting also the ventral and lateral funiculi	31554
lesions	31554
the ventral and lateral funiculi	31577
severe motor deficits	31616
Adamson	31639
et al. , 1989	31647
et al.	31647
1989	31655
Kawai and Nagao , 1992	31661
Kawai and Nagao	31661
1992	31678
Schlag et al. , 2001	31684
Schlag	31684
et al. , 2001	31691
et al.	31691
2001	31699
Schucht et al. , 2002	31705
Schucht	31705
et al. , 2002	31713
et al.	31713
2002	31721
The results	31728
the density of blood vessel profiles	31750
the density	31750
blood vessel profiles	31765
about 30 % in OEC-transplanted rats	31797
about 30 %	31797
OEC-transplanted rats	31810
respect	31837
unlesioned rats	31848
the COX-2 and VEGF reactivity grade	31869
about 8 - and 6-fold higher in OECtransplanted rats	31909
8	31915
OECtransplanted	31939
unlesioned animals	31968
Significant positive correlations	31988
COX-2 and VEGF reactivity grades	32041
VEGF reactivity grade and density of blood vessels	32083
VEGF reactivity grade	32083
density of blood vessels	32109
density	32109
blood vessels	32120
density of blood vessels	32147
density	32147
blood vessels	32158
preserved spinal cord parenchyma -LRB- Table 2 -RRB-	32176
preserved spinal cord parenchyma	32176
Table 2	32210
It	32220
OECs transplanted into the lesioned cord	32240
OECs	32240
the lesioned cord	32263
the	32263
cord	32276
these responses	32302
In vitro OECs	32319
several neurotrophic molecules	32341
nerve growth factor -LRB- NGF -RRB-	32380
nerve growth factor	32380
NGF	32401
brain-derived neurotrophic factor -LRB- BDNF -RRB-	32407
brain-derived neurotrophic factor	32407
BDNF	32442
neurotrophin 4/5	32449
neurotrophin	32449
4/5	32462
glial cell linederived neurotrophic factor -LRB- GDNF -RRB-	32467
glial cell linederived neurotrophic factor	32467
glial cell	32467
neurotrophic factor	32490
GDNF	32511
their receptors	32521
Ramón-Cueto	32538
et al. , 1993	32550
et al.	32550
1993	32558
Boruch et al. , 2001	32564
Boruch	32564
et al. , 2001	32571
et al.	32571
2001	32579
Woodhall et al. , 2001	32585
Woodhall	32585
et al. , 2001	32594
et al.	32594
2001	32602
Lipson et al. , 2003	32608
Lipson	32608
et al. , 2003	32615
et al.	32615
2003	32623
Vincent et al. , 2003	32629
Vincent	32629
et al. , 2003	32637
et al.	32637
2003	32645
Au and Roskams -LRB- 2003 -RRB-	32662
Au and Roskams	32662
2003	32678
OECs from lamina propia , which display Schwann-like properties ,	32698
OECs	32698
lamina propia	32708
Schwann-like properties	32737
VEGF and PACAP	32775
it	32805
OECs	32822
all these molecules in vivo	32847
all these molecules	32847
vivo	32870
transplantation	32881
The results reported in the present study	32898
The results	32898
the present study	32922
the first evidence	32948
transplanted OECs	32972
functional recovery	32998
loss of cord parenchyma	33030
loss	33030
cord parenchyma	33038
incomplete spinal cord injury by means of neoangiogenesis	33060
incomplete spinal cord injury	33060
means of neoangiogenesis	33093
means	33093
neoangiogenesis	33102
upregulation of COX-2 and VEGF	33135
upregulation	33135
COX-2 and VEGF	33151
intact spinal cord	33170
COX-2 mRNA and protein	33190
COX-2 mRNA	33190
protein	33205
neurons of all laminae	33232
neurons	33232
all laminae	33243
white matter	33262
glial cells	33275
astrocytes -LRB- Vanegas and Schaible , 2001 -RRB-	33304
astrocytes	33304
Vanegas and Schaible	33316
2001	33338
injury	33351
COX-2 and PGE2 immunoreactivity	33359
protein levels	33395
Resnick et al. , 1998 ; Hirst et al. , 1999 ; Hains et al. , 2001	33411
Resnick	33411
et al. , 1998 ; Hirst et al. , 1999 ; Hains et al. , 2001	33419
et al. , 1998	33419
et al.	33419
1998	33427
Hirst et al. , 1999	33433
Hirst	33433
et al. , 1999	33439
et al.	33439
1999	33447
Hains et al. , 2001	33453
Hains	33453
et al. , 2001	33459
et al.	33459
2001	33467
the lesion site	33486
high levels	33519
the first 14 days postinjury	33538
A number of in vivo studies	33568
A number	33568
vivo studies	33583
inhibition of COX	33614
inhibition	33614
COX	33628
a protective effect against ischemic damage -LRB- Yamamoto et al. , 1995 -RRB-	33636
a protective effect	33636
ischemic damage -LRB- Yamamoto et al. , 1995 -RRB-	33664
ischemic damage	33664
Yamamoto	33681
et al. , 1995	33690
et al.	33690
1995	33698
kainic-acid	33705
neurotoxicity -LRB- Baran et al. , 1994 -RRB-	33725
neurotoxicity	33725
Baran	33740
et al. , 1994	33746
et al.	33746
1994	33754
spinal cord contusion -LRB- Resnick et al. , 1998 ; Hains et al. , 2001 -RRB-	33765
spinal cord contusion	33765
Resnick	33788
et al. , 1998 ; Hains et al. , 2001	33796
et al.	33796
1998 ; Hains et al.	33804
1998	33804
Hains et al.	33810
Hains	33810
et al.	33816
2001	33824
The cytotoxicity of COX-2	33831
The cytotoxicity	33831
COX-2	33851
part	33876
generation	33884
reactive oxygen species	33898
the peroxidase step	33934
the COX reaction	33957
PGG2	33983
PGH2 -LRB- Tsai et al. , 1994 -RRB-	34004
PGH2	34004
Tsai	34010
et al. , 1994	34015
et al.	34015
1994	34023
stimulation of the calcium-dependent glutamate release	34037
stimulation	34037
the calcium-dependent glutamate release	34052
astrocytes	34097
prostaglandins -LRB- Bezzi et al. , 1998 -RRB-	34111
prostaglandins	34111
Bezzi	34127
et al. , 1998	34133
et al.	34133
1998	34141
contrast	34151
several in vitro studies	34161
several	34161
prostaglandins	34202
protective effects	34227
rat neurons following glutamate , nitric oxide , and hypoxic damage	34258
rat neurons	34258
glutamate , nitric oxide , and hypoxic damage	34280
glutamate	34280
nitric oxide	34291
hypoxic damage	34309
Akaike et al. , 1994 ; Otsuki et al. , 1994 ; Kikuchi et al. , 2002	34325
Akaike	34325
et al. , 1994 ; Otsuki et al. , 1994 ; Kikuchi et al. , 2002	34332
et al. , 1994	34332
et al.	34332
1994	34340
Otsuki et al. , 1994	34346
Otsuki	34346
et al. , 1994	34353
et al.	34353
1994	34361
Kikuchi et al. , 2002	34367
Kikuchi	34367
et al. , 2002	34375
et al.	34375
2002	34383
it	34396
a matter of controversy	34408
a matter	34408
controversy	34420
COX-2 and prostaglandins	34440
a beneficial or a detrimental effect	34470
the injured tissue	34510
The results of the present study	34530
The results	34530
the present study	34545
upregulation of COX-2 expression induced by OEC-transplants	34576
upregulation	34576
COX-2 expression induced by OEC-transplants	34592
COX-2 expression	34592
OEC-transplants	34620
a neuroprotective role	34642
the first days postlesion	34672
spinal cord injury	34705
the expression of VEGF and its receptors	34725
the expression	34725
VEGF and its receptors	34743
VEGF	34743
its receptors	34752
the lesioned area	34782
an in vitro model	34807
model	34819
cell cultures of meningeal fibroblasts and astrocytes	34830
cell cultures	34830
meningeal fibroblasts and astrocytes	34847
it	34885
VEGF	34908
astrocytes	34929
treatment	34946
PGF2alpha and PGE2 -LRB- Sköld et al. , 2000 -RRB-	34961
PGF2alpha and PGE2	34961
Sköld	34981
et al. , 2000	34987
et al.	34987
2000	34995
All these findings	35002
a relationship between COX - 2 , prostaglandins and VEGF	35030
a relationship between COX	35030
a relationship	35030
COX	35053
2 , prostaglandins and VEGF	35058
2	35058
prostaglandins	35061
VEGF	35080
spinal cord injuries	35091
VEGF	35113
endothelial cell proliferation , angiogenesis , vascular permeability	35127
Proescholdt	35196
et al. , 1999	35208
et al.	35208
1999	35216
Bartholdi et al. , 1997	35222
Bartholdi	35222
et al. , 1997	35232
et al.	35232
1997	35240
Salhia et al. , 2000	35246
Salhia	35246
et al. , 2000	35253
et al.	35253
2000	35261
Facchiano et al. , 2002	35267
Facchiano	35267
et al. , 2002	35277
et al.	35277
2002	35285
it	35296
the extent	35324
corticospinal axon retrograde degeneration -LRB- Facchiano et al. , 2002 -RRB-	35338
corticospinal axon retrograde degeneration	35338
Facchiano	35382
et al. , 2002	35392
et al.	35392
2002	35400
Casella et al. -LRB- 2002 -RRB-	35417
Casella et al.	35417
Casella	35417
et al.	35425
2002	35433
a vigorous growth of new blood vessels	35448
a vigorous growth	35448
new blood vessels	35469
between 4 and 7 days	35487
moderate spinal cord contusion	35514
7 days postinjury	35549
the newly formed vessels	35568
reactive astrocytes	35614
summary	35638
neoangiogenesis	35647
the upregulation of COX-2 , prostaglandins and VEGF	35679
the upregulation	35679
COX-2 , prostaglandins and VEGF	35699
spinal cord blood supply	35739
hypoxia and neuronal death	35773
hypoxia	35773
neuronal death	35785
formation of a substrate	35814
formation	35814
a substrate	35827
laminin	35847
the disrupted axons	35861
the neoformation of blood vessels	35924
the neoformation	35924
blood vessels	35944
spinal cord injury	35972
a potential repair strategy	35998
a natural bridge	36035
axonal regeneration	36075
nutritional support	36109
agreement with our results	36133
agreement	36133
our results	36148
slightly higher numbers of blood vessels	36161
slightly higher numbers	36161
blood vessels	36188
OEC	36224
DMEMinjected rats after spinal cord contusion	36237
DMEMinjected rats	36237
spinal cord contusion	36261
the spared spinal cord tissue	36288
43 % and 33 % in the same experimental groups	36328
43 % and 33 %	36328
the same experimental groups	36343
Takami	36375
et al. -LRB- 2002 -RRB-	36382
et al.	36382
2002	36390
Previous studies from our laboratory	36397
Previous studies	36397
our laboratory	36419
OECs	36446
the reactivity	36472
astrocytes	36490
their expression of GFAP and proteoglycan	36513
their expression	36513
GFAP and proteoglycan	36533
a spinal cord injury -LRB- Verdú et al. , 2001 , 2003 -RRB-	36561
a spinal cord injury	36561
Verdú	36583
et al. , 2001 , 2003	36589
et al.	36589
2001	36597
2003	36603
Preliminary studies	36610
larger numbers of LEC-positive round cells	36644
larger numbers	36644
LEC-positive round cells	36662
the spinal cord parenchyma at 7 dpo in OEC rats	36703
the spinal cord parenchyma	36703
7 dpo in OEC rats	36733
7 dpo	36733
OEC rats	36742
DMEM rats	36759
the reverse	36776
14 dpo -LRB- unpublished observations -RRB-	36800
14 dpo	36800
unpublished observations	36808
The restorative ability	36835
OEC transplants	36862
spinal cord parenchyma preservation via modulation of microglia	36891
spinal cord parenchyma preservation	36891
modulation of microglia	36931
modulation	36931
microglia	36945
macrophage reactivity	36956
further investigation	36984
